Search Results 191-200 of 17350 for hba1c

  1. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Subjects with type 2 diabetes who are on stable doses of medications (except pioglitazone) to control hyperglycemia and have baseline HbA1c of 10% or lower.

  2. A Study to Evaluate the Effectiveness and Safety of Elafibranor for Patients with Nonalcoholic Fatty Liver Disease - Mayo Clinic

    Decompensated diabetes (HbA1c>9%); A history of clinically significant acute cardiac event within 6 months prior to screening; Weight loss of more than 5 ...

  3. Glycemic index: A helpful tool for diabetes? - Mayo Clinic

    The glycemic index classifies foods that contain carbohydrates according to their potential to raise blood sugar. Foods with high glycemic index values tend ...

  4. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

    HbA1c ≤ 8%;. Negative serum pregnancy test within 72 hours before starting study treatment in women with childbearing potential;; Women of childbearing ...

  5. The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Partial Lipodystrophy - Mayo Clinic

    Diabetes not well controlled on antidiabetic therapy with HbA1c ≥ 7% to ≤ 12% at Screening; Hypertriglyceridemia with Fasting TG levels ≥ 500 mg/dL ...

  6. Fuchs' Dystrophy Clinical Trials - Mayo Clinic Research

    ... (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees ...

  7. A Study of the Effects of Inflammation on Fat Tissue and Insulin in People with Different Body Shapes - Mayo Clinic

    For Type II Diabetic volunteers they will need a HbA1C between 7.0% and 9.5%. As with obese participants (above), transaminase, glucose and lipid values are ...

  8. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

    HbA1c > 8.5% at Screening. History or concurrent condition of interstitial lung disease and/or severely impaired lung function (as judged by the ...

  9. A Study to Optimize Patient Selection and Outcomes in Laryngeal Vascular Composite Allograft Transplantation - Mayo Clinic

    Once HbA1C < 7, reevaluate for candidacy. Active smoking within 6 months. Active alcoholism within 6 months. Active substance use within 6 months. Pregnancy ...

  10. Laryngeal Allograft Transplantation - Clinical Trials

    Once HbA1C < 7, reevaluate for candidacy. - Active substance use within 6 months - Active smoking within 6 months - Active alcoholism within 6 months - ...